Inozyme Pharma logo
Inozyme Pharma INZY
$ 2.71 -2.87%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Inozyme Pharma Income Statement 2011-2024 | INZY

Annual Income Statement Inozyme Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

297 M 102 M 161 M 381 M - - - - - - - - -

Shares

51.8 M 37.8 M 23.6 M 18.1 M - - - - - - - - -

Historical Prices

5.72 2.69 6.82 20.6 - - - - - - - - -

Net Income

-71.2 M -67.1 M -56.6 M -56.4 M -19.7 M -6.96 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-75.6 M -68.7 M -56.6 M -57 M -20.8 M - - - - - - - -

Interest Expense

3.33 M 262 K -189 K 247 K -24 K - - - - - - - -

EBITDA

-74.8 M -68 M -56 M -56.8 M -20.7 M -11.6 M - - - - - - -

Operating Expenses

75.6 M 68.7 M 56.6 M 57 M 20.8 M 11.6 M - - - - - - -

General and Administrative Expenses

20.8 M 20.8 M 18.9 M 10.5 M 4.59 M 3.49 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Inozyme Pharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

63.3 M 61.9 M 61.8 M 61.8 M 56.8 M 44.9 M 43.7 M 40.4 M 43.7 M 39.7 M 23.7 M 23.7 M 23.6 M 23.5 M 23.4 M 23.4 M 18.1 M 1.25 M 1.21 M 1.2 M 1.2 M 1.17 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-24.6 M -27 M -23.3 M - -16.6 M -15.6 M -17.4 M - -16.4 M -15.3 M -16.9 M - -14.3 M -12.5 M -11 M - 56.4 M -56.4 M -56.4 M - -19.7 M -19.7 M -4.97 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-24.9 M -27.7 M -24.3 M - -18.1 M -16.4 M -18.4 M - -16.9 M -15.4 M -16.8 M - -14.3 M -12.7 M -11 M - -28.3 M -9.55 M -7.91 M - -4.32 M -4.55 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-81 K 1.4 M 1.32 M - 20 K 771 K 328 K - -197 K -191 K -105 K - -65 K 57 K -141 K - 157 K 4 K -3 K - -3 K -14 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -24.2 M - - - -18.2 M - -16.7 M -15.2 M -16.7 M - -14.1 M -12.5 M -10.8 M - -28.3 M -9.52 M -7.88 M - -4.3 M -4.53 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

24.9 M 27.7 M 24.3 M - 18.1 M 16.4 M 18.4 M - 16.9 M 15.4 M 16.8 M - 14.3 M 12.7 M 11 M - 28.3 M 9.55 M 7.91 M - 4.32 M 4.55 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

4.96 M 5.91 M 5.23 M - 4.73 M 4.73 M 6.51 M - 4.72 M 5.38 M 5.02 M - 4.92 M 4.44 M 4.37 M - 3.14 M 1.67 M 1.5 M - 1 M 1.06 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency